INSM
Insmed Inc
121.60$
+2.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 71.3% | 80.8% | 70.8% | 84.3% | 85.8% | 74.8% | 78.2% | 67.3% | 76.9% | 69.9% | 80.1% | 79.2% | |
| 69.0% | 79.3% | 68.3% | 82.5% | 81.9% | 65.7% | 66.9% | 57.6% | 64.8% | 36.3% | 27.4% | 22.5% | |
| 69.0% | 79.3% | 68.3% | 82.5% | 81.9% | 65.7% | 66.9% | 57.6% | 69.3% | 58.7% | 70.8% | 63.1% | |
| – | – | – | – | 0.9% | 2.6% | 2.1% | 2.0% | 1.8% | 3.1% | 2.6% | 6.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 1.2% | 3.8% | 6.2% | 5.4% | 4.2% | 6.3% | 4.9% | 5.8% | |
| 3.3% | 2.3% | 4.2% | 2.7% | 3.7% | 8.1% | 6.8% | 4.3% | 3.4% | – | – | – | |
| 25.2% | 16.3% | 24.5% | 12.6% | 9.7% | 7.2% | 6.2% | 10.9% | 8.2% | 10.2% | 6.7% | 6.0% | |
| 25.2% | 16.3% | 24.5% | 12.6% | 9.7% | 7.2% | 6.2% | 5.9% | 4.2% | 4.8% | 2.9% | 4.3% | |
| 19.3% | 12.6% | 35.1% | 21.9% | 65.6% | 64.7% | 65.3% | 67.0% | 94.7% | 125.0% | 85.9% | 67.4% | |
| 8.5% | 6.2% | 11.8% | 9.7% | 13.2% | 11.5% | 14.9% | 10.9% | 11.5% | 17.0% | 14.7% | 20.7% | |
| 10.8% | 0.9% | 23.0% | 12.0% | – | 1.7% | 1.6% | 0.8% | 0.5% | 0.8% | 0.8% | 0.9% | |
| 4.0% | 2.1% | 4.4% | 3.2% | 2.9% | 1.8% | 5.4% | 2.9% | 3.0% | 4.9% | 3.6% | 3.5% | |
| 10.8% | 6.2% | 23.0% | 12.0% | 52.4% | 45.3% | 44.8% | 45.6% | 67.9% | 86.9% | 54.5% | 23.9% | |
| 80.7% | 87.4% | 64.9% | 78.1% | 34.4% | 35.3% | 34.7% | 33.0% | 5.3% | -25.0% | 14.1% | 32.6% | |
| -203.9% | -165.2% | -321.6% | -207.3% | -212.1% | -207.0% | -229.9% | -182.2% | -162.8% | -259.1% | -215.3% | -248.9% | |
| 18.7% | 16.4% | 26.0% | 14.4% | 12.7% | 11.4% | 12.3% | 9.0% | 7.4% | 10.6% | 8.1% | 9.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.